WebDisclosure WebDisclosure
Basculer en Français
10242 Companies
211487 Keywords
141388 Articles
112023 Press releases
Headlines Articles Press releases Novigenix AI Remove
  1. Home
  2. Companies
  3. Novigenix AI
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 03/05/2026 at 09:10, 1 month 15 days ago

    Novigenix AI Launches First AI-Powered Immune Intelligence Platform

    AI-powered Precision Medicine Clinical Applications Immune Intelligence LITOSeek® Platform
  • BRIEF

    published on 03/05/2026 at 09:10, 1 month 15 days ago

    Novigenix AI lance la première plateforme d'intelligence immunitaire basée sur l'IA

    Alimenté Par L'IA Médecine De Précision Applications Cliniques Intelligence Immunitaire Plateforme LITOSeek®
  • PRESS RELEASE

    published on 03/05/2026 at 09:05, 1 month 15 days ago

    Novigenix AI Spin-Out to Accelerate AI-Powered Immune Intelligence

    Novigenix AI Spin-Out to Accelerate AI-Powered Immune Intelligence. Novigenix SA launches Novigenix AI, a precision medicine company commercializing LITOSeek platform for therapy development and immune intelligence
    AI-powered Precision Medicine Immune Intelligence Novigenix AI LITOSeek Platform
    Logo of Novigenix AI
Accesswire
  • Published on 04/20/2026 at 12:00, 7 minutes ago

    Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement and Provides Corporate Update

  • Published on 04/20/2026 at 09:00, 3 hours 7 minutes ago

    Ameriwest Completes 3D Geological Model Defining High-Grade Copper Shell Along with Two Additional Zones at the Bornite Project

  • Published on 04/20/2026 at 08:00, 4 hours 7 minutes ago

    QNX and NVIDIA Deepen Collaboration to Advance Safety-Critical Edge AI Across Robotics, Medical, and Industrial Systems

  • Published on 04/20/2026 at 04:00, 8 hours 7 minutes ago

    Leapmotor Selects QNX for D19 Premium Electric SUV, Production Starts April 2026

  • Published on 04/20/2026 at 02:25, 9 hours 42 minutes ago

    First Challenger Assays Return Grades up to 170g/t Au

View all ACCESSWIRE
EQS Group
  • Published on 04/20/2026 at 11:49, 17 minutes ago

    POS-Transaction in Own Shares

  • Published on 04/20/2026 at 11:41, 25 minutes ago

    Aroundtown SA: Release of a capital market information

  • Published on 04/20/2026 at 11:20, 46 minutes ago

    Amundi Physical Metals plc: UK Final Terms

  • Published on 04/20/2026 at 11:20, 46 minutes ago

    CTS EVENTIM: Extension of Ticketing Partnership Between CTS EVENTIM and Stage Entertainment

  • Published on 04/20/2026 at 11:16, 50 minutes ago

    Amundi Physical Metals plc: Final Terms

View all EQS
Les Echos
  • Published on 04/20/2026 at 08:00, 4 hours 7 minutes ago

    First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

  • Published on 04/20/2026 at 08:00, 4 hours 7 minutes ago

    Une étude médico‑économique menée pour la première fois dans les pays du G7 démontre que le recours précoce à des tests de diagnostic rapides face au sepsis pourrait sauver des milliers de vies et générer des économies pour les systèmes de s

  • Published on 04/20/2026 at 07:00, 5 hours 7 minutes ago

    Invitation to the Annual and Extraordinary General Meeting of Shareholders

  • Published on 04/20/2026 at 07:00, 5 hours 7 minutes ago

    Uitnodiging voor de Jaarvergadering en Buitengewone Algemene Vergadering van aandeelhouders

  • Published on 04/20/2026 at 07:00, 5 hours 7 minutes ago

    Invitation to the Annual and Extraordinary General Meeting of Shareholders

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy